Cargando…

Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination: cases from a regional pharmacovigilance centre

In this article we summarize suspected adverse events following immunization (AEFI) of pericarditis, myocarditis and perimyocarditis that were reported by our regional pharmacovigilance centre after COVID-19 mRNA-vaccination and discuss their association with these vaccines. Seventeen cases were rep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Istampoulouoglou, Ioanna, Dimitriou, Georgios, Späni, Selina, Christ, Andreas, Zimmermanns, Barbara, Koechlin, Sarah, Stoeckmann, Oliver, Winterhalder, Clemens, Marono, David, Toma, Valeriu, Leuppi-Taegtmeyer, Anne B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Magdi Yacoub Heart Foundation 2021
Materias:	Pharmacovigilance
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8587334/ https://www.ncbi.nlm.nih.gov/pubmed/34805376 http://dx.doi.org/10.21542/gcsp.2021.18

Ejemplares similares

Cardiovascular adverse effects of lopinavir/ritonavir and hydroxychloroquine in COVID-19 patients: Cases from a single pharmacovigilance centre
por: Istampoulouoglou, Ioanna, et al.
Publicado: (2021)

A case of intoxication with tea made from Digitalis purpurea
por: Lehmann, Anouk, et al.
Publicado: (2021)

Torsade de pointes and systemic azole antifungal agents: Analysis of global spontaneous safety reports
por: Salem, M., et al.
Publicado: (2017)

Pharmacovigilance des médicaments et des vaccins contre la COVID-19 durant la pandémie : comment le Réseau français des centres régionaux de pharmacovigilance a relevé le défi ?
por: Jonville-Bera, Annie Pierre, et al.
Publicado: (2023)

A day in the life of a pharmacovigilance case processor
por: Bhangale, Ritesh, et al.
Publicado: (2017)

Global research output in ‘pharmacovigilance’ during 2010–2020
por: Tyagi, Sunil
Publicado: (2022)

Nirmatrelvir/ritonavir (Paxlovid®): French pharmacovigilance survey 2022
por: Bihan, Kevin, et al.
Publicado: (2023)

Pharmacovigilance for clinical trials in India: Current practice and areas for reform
por: Brahmachari, Ballari, et al.
Publicado: (2011)

Pharmacovigilance follow-up of patients in the context of the COVID-19 pandemic
por: Grandvuillemin, Aurélie, et al.
Publicado: (2023)

French pharmacovigilance survey of casirivimab - imdevimab monoclonal antibodies in coronavirus disease (COVID-19)
por: de Canecaude, Claire, et al.
Publicado: (2023)

Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran)
por: Valnet-Rabier, Marie-Blanche, et al.
Publicado: (2023)

COVID-19 et vaccins à adénovirus : expérience française de suivi renforcé de pharmacovigilance
por: Massy, Nathalie, et al.
Publicado: (2023)

Peripheral facial palsy post SARS-CoV-2 vaccine: A regional pharmacovigilance cases series
por: Chamboux, Morgane, et al.
Publicado: (2023)

Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: A win-win bet with Health Authorities!
por: Jonville-Bera, Annie Pierre, et al.
Publicado: (2023)

Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: The French perspective
por: Salvo, Francesco, et al.
Publicado: (2023)

Pharmacovigilance and assessment of drug safety reports during COVID 19
por: Desai, Mira K
Publicado: (2020)

Drug safety alerts of pharmacovigilance programme of India: A scope for targeted spontaneous reporting in India
por: Thota, Prasad, et al.
Publicado: (2018)

Causality assessment: A brief insight into practices in pharmaceutical industry
por: Naidu, R. Purushotham
Publicado: (2013)

A thorough QTc study demonstrates that olmesartan medoxomil does not prolong the QTc interval
por: Mendell, Jeanne, et al.
Publicado: (2015)

Patterns of the initiation of disease-modifying antirheumatic drugs in incident rheumatoid arthritis: a German perspective based on nationwide ambulatory drug prescription data
por: Steffen, Annika, et al.
Publicado: (2018)

Understanding the molecular–pharmaceutical basis of sartan recalls focusing on valsartan
por: Ray, Avik, et al.
Publicado: (2020)

Comparative study of the adverse event profile of hydroxychloroquine before and during the Sars-CoV2 pandemic
por: Lory, Pauline, et al.
Publicado: (2022)

Colchicine and macrolides: a cohort study of the risk of adverse outcomes associated with concomitant exposure
por: Tan, Malinda S., et al.
Publicado: (2022)

Vaccines and Bell's palsy: A narrative review
por: Bertin, Blandine, et al.
Publicado: (2023)

The winding 12-month journey of the AstraZeneca COVID-19 vaccine since its first administration to humans
por: Dal-Ré, Rafael
Publicado: (2023)

Safety profile of the lopinavir/ritonavir combination before and during the SARS-CoV-2 pandemic
por: Lory, Pauline, et al.
Publicado: (2022)

French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge
por: Lacroix, Clémence, et al.
Publicado: (2021)

Pharmacovigilance in China: Evolution and future challenges
por: Song, Haibo, et al.
Publicado: (2022)

Development and Implementation of an e-Trigger Tool for Adverse Drug Events in a Swiss University Hospital
por: El Saghir, Amina, et al.
Publicado: (2021)

Enhancing self-medication practices in the era of infodemic: the role of pharmacovigilance
por: Calderon-Ospina, Carlos-Alberto
Publicado: (2023)

Small intestinal injury in NSAID users suffering from rheumatoid arthritis or osteoarthritis
por: Tachecí, Ilja, et al.
Publicado: (2016)

Analysis of serious adverse event: Writing a narrative
por: Nambiar, Indu
Publicado: (2018)

Long-term use of biologic agents does not increase the risk of serious infections in elderly patients with rheumatoid arthritis
por: Kawashima, Hirotoshi, et al.
Publicado: (2016)

The response to the COVID-19 pandemic trusted in pharmacovigilance to diminish communication risk
por: Quintero, Gustavo A.
Publicado: (2022)

Global safety monitoring of COVID-19 vaccines: how pharmacovigilance rose to the challenge
por: Rudolph, Annette, et al.
Publicado: (2022)

Myocarditis and Pericarditis Post-mRNA COVID-19 Vaccination: Insights from a Pharmacovigilance Perspective
por: Alami, Abdallah, et al.
Publicado: (2023)

Effects of the Fluoroquinolones Moxifloxacin and Levofloxacin on the QT Subintervals: Sex Differences in Ventricular Repolarization
por: Täubel, Jӧrg, et al.
Publicado: (2019)

COVID-19, Myocarditis and Pericarditis
por: Fairweather, DeLisa, et al.
Publicado: (2023)

Gastrointestinal bleeding during anticoagulation with direct oral anticoagulants compared to vitamin K antagonists
por: Dongre, Kanchan, et al.
Publicado: (2022)

Myocarditis and Pericarditis in Patients with COVID-19
por: Shah, Jassim Zaheen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kmc6mknnjkg9jf7o0c8nu617qm